T. Schachtner

Short-term effects of an SGLT2 inhibitor on divalent ions in autosomal dominant polycystic kidney disease: a randomized crossover trial

No substantial short-term difference in urinary or fractional excretion of divalent ions were detected with empagliflozin in this exploratory mechanistic trial, and the observed changes in serum magnesium, urinary citrate, uric acid, and copeptin are hypothesis-generating and require confirmation in larger, longer-term...